NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
National Institutes of Health
The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders...more


Minority Research Grant Program 2024
Centers for Medicare & Medicaid Services
The Minority Research Grant Program, authorized under Section 1110 of the Social Security Act, provides funding opportunities to support health equity research. The purpose of this Notice of Funding...more

Expanding Outreach and Professional Training to Engage Older Adults with Behavioral Health Conditions in Evidence-Based Health Promotion Programs
Administration for Community Living
The purpose of this funding opportunity is to provide leadership, expert guidance, training, and resources to community-based organizations and aging and disability service providers to increase the...more

Revolving Fund Program
Administration for Community Living
This program provides grants to qualified private, non-profit entities to capitalize revolving funds for the purpose of providing financing to eligible entities for pre-development costs associated...more

Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to solicit applications to participate in the Immunobiology of Xenotransplantation Cooperative Research Program (IXCRP), a multi-center...more

Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed)
National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is to support milestone-driven projects focused on developing and utilizing novel predictive models, assays, tools, and/or platforms based on...more

Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to solicit applications to participate in the Immunobiology of Xenotransplantation Cooperative Research Program (IXCRP), a multi-center...more

Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed)
National Institutes of Health
This Notice of Funding Opportunity (NOFO) requests applications to explore human pancreatic tissues and the immune compartment for the discovery of specific signaling or processing pathways that may...more

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
National Institutes of Health
The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders...more

Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial Optional)
National Institutes of Health
The main objective of this NOFO is to foster development and testing of technologies adaptable to aging-related changes in older adults (aged 65 years or older) with T1D to improve diabetes...more